Verana Health is a health technology company dedicated to assembling the largest clinical databases in medicine to empower physicians and accelerate research for patients.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
01/14/2022 | Series E | $150MM | $xx.xx | $53.16B | Breyer Capital, Brook Byers, Casdin Capital, Gv, Johnson & Johnson Innovation, Merck Global Health Innovation Fund, Novo Growth, Thvc | |
Price per Share
$xx.xx
Shares Outstanding
71,442,179
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Breyer Capital, Brook Byers, Casdin Capital, Gv, Johnson & Johnson Innovation, Merck Global Health Innovation Fund, Novo Growth, Thvc
|
||||||
02/05/2020 | Series D | $100MM | $xx.xx | $25.69B | Bain Capital Ventures, Casdin Capital, Define Ventures, Google Ventures | |
Price per Share
$xx.xx
Shares Outstanding
50,027,508
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bain Capital Ventures, Casdin Capital, Define Ventures, Google Ventures
|
||||||
07/31/2018 | Series C | $32.98MM | $xx.xx | $4.94B | Biomatics Capital, Brook Byers, Caufield & Byers, Ge Ventures, Google Ventures, Lagunita Biosciences, Perkins | |
Price per Share
$xx.xx
Shares Outstanding
41,223,930
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Biomatics Capital, Brook Byers, Caufield & Byers, Ge Ventures, Google Ventures, Lagunita Biosciences, Perkins
|
||||||
02/09/2015 | Series B | $14.05MM | $xx.xx | $2.19B | Biosys Capital, Ge Ventures, Lagunita Llc, Waycross Ventures | |
Price per Share
$xx.xx
Shares Outstanding
4,705,415
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.9x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Biosys Capital, Ge Ventures, Lagunita Llc, Waycross Ventures
|
||||||
01/01/2013 | Series A | $920,982.00 | $xx.xx | $460.49MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
418,628
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.7x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|